{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:53:38Z","timestamp":1773298418375,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"GW Research Ltd"},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","award":["602391"],"award-info":[{"award-number":["602391"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bbr.2019.01.040","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T13:48:20Z","timestamp":1548337700000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"363","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-3040","authenticated-orcid":false,"given":"Ines","family":"Serra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00eb","family":"Scheldeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bazelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.M.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.01.040_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbr.2019.01.040_bib0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2019.01.040_bib0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","article-title":"Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome","volume":"156","author":"Menon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2019.01.040_bib0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","article-title":"Role of mTOR in physiology and pathology of the nervous system","volume":"1784","author":"Swiech","year":"2008","journal-title":"Biochim. Biophys. Acta - Proteins Proteomics"},{"key":"10.1016\/j.bbr.2019.01.040_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","article-title":"The mTOR signalling cascade: paving new roads to cure neurological disease","volume":"12","author":"Crino","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2019.01.040_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.spen.2015.10.002","article-title":"Genotype\/Phenotype correlations in tuberous sclerosis complex","volume":"22","author":"Curatolo","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0045","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0050","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1177\/0883073817737446","article-title":"Predictors of drug-resistant epilepsy in tuberous sclerosis complex","volume":"32","author":"Jeong","year":"2017","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","article-title":"The tuberous sclerosis complex proteins - a GRIPP on cognition and neurodevelopment","volume":"13","author":"de Vries","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbr.2019.01.040_bib0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2011.10.005","article-title":"Cognitive and adaptive development of patients with tuberous sclerosis complex: a retrospective, longitudinal investigation","volume":"23","author":"van Eeghen","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbr.2019.01.040_bib0070","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-0035-1552616","article-title":"Epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments","volume":"35","author":"Saxena","year":"2015","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0075","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/epi.12430","article-title":"Epilepsy in TSC: certain etiology does not mean certain prognosis","volume":"54","author":"Vignoli","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0080","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.01.040_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) -- baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbr.2019.01.040_bib0090","first-page":"1","article-title":"New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND) [version 1 ; referees : 3 approved] Referee Status","volume":"6","author":"Gipson","year":"2017"},{"key":"10.1016\/j.bbr.2019.01.040_bib0095","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2019.01.040_bib0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0105","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s11064-017-2287-8","article-title":"Evaluation of cannabidiol in animal seizure models by the epilepsy therapy screening program (ETSP)","volume":"42","author":"Klein","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2017.07.014","article-title":"Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels","volume":"75","author":"Vilela","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbr.2019.01.040_bib0115","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2019.01.040_bib0120","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2019.01.040_bib0125","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1158\/1535-7163.MCT-12-0335","article-title":"COX-2 and PPAR- gamma confer cannabidiol-induced apoptosis of human lung Cancer cells","volume":"12","author":"Ramer","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbr.2019.01.040_bib0135","article-title":"Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87- MG and T98G glioma cells through a multitarget effect","volume":"8","author":"Solinas","year":"2013","journal-title":"plos biol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3747\/co.23.2893","article-title":"In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma","volume":"23","author":"Fisher","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-016-1280-0","article-title":"Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells","volume":"16","author":"Lukhele","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bbr.2019.01.040_bib0150","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbr.2019.01.040_bib0155","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-010-1177-4","article-title":"Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis","volume":"129","author":"Mcallister","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbr.2019.01.040_bib0165","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1096\/fj.11-198184","article-title":"Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1","volume":"26","author":"Ramer","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2019.01.040_bib0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","article-title":"Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: possible role of the mTOR pathway and reduction in glutamate release","volume":"50","author":"Gobira","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2019.01.040_bib0175","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00144","article-title":"Cannabidiol reduces leukemic cell size \u2013 but is it important?","volume":"8","author":"Kalenderoglou","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0190","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","author":"Sales","year":"2018","journal-title":"Mol. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1167.2009.02295.x","article-title":"Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications","volume":"50","author":"Wong","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0205","series-title":"Organism Models of Autism Spectrum Disorders","author":"Roubertoux","year":"2015"},{"key":"10.1016\/j.bbr.2019.01.040_bib0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1242\/dmm.005587","article-title":"Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin","volume":"4","author":"Kim","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbr.2019.01.040_bib0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14737175.2018.1428562","article-title":"mTOR dysregulation and tuberous sclerosis-related epilepsy","volume":"18","author":"Curatolo","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbr.2019.01.040_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2015.00075","article-title":"Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function","volume":"8","author":"Biever","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2017.09.004","article-title":"mTOR-related neuropathology in mutant tsc2 zebrafish : phenotypic, transcriptomic and pharmacological analysis","volume":"108","author":"Scheldeman","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2019.01.040_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yebeh.2012.02.020","article-title":"Anticonvulsant activity of bisabolene sesquiterpenoids of Curcuma longa in zebrafish and mouse seizure models","volume":"24","author":"Orellana-Paucar","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbr.2019.01.040_bib0235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-014-3656-5","article-title":"Differential behavioral responses of zebrafish larvae to yohimbine treatment","volume":"232","author":"Li","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.01.040_bib0240","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/FBP.0000000000000312","article-title":"Behavioural responses of zebrafish larvae to acute ethosuximide exposure","volume":"28","author":"Ji","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.46867\/IJCP.2010.23.01.02","article-title":"Genetic analysis of the touch response in zebrafish (Danio rerio)","volume":"23","author":"Carmean","year":"2010","journal-title":"Int. J. Comp. Psychol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0250","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbr.2019.01.040_bib0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.yebeh.2011.08.016","article-title":"Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models","volume":"22","author":"Vermoesen","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbr.2019.01.040_bib0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbr.2011.12.016","article-title":"Measuring thigmotaxis in larval zebrafish","volume":"228","author":"Schn\u00f6rr","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0265","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1242\/jeb.003939","article-title":"Modulation of locomotor activity in larval zebrafish during light adaptation","volume":"210","author":"Burgess","year":"2007","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jocn.2012.09.010","article-title":"Ethanol modifies zebrafish responses to abrupt changes in light intensity","volume":"20","author":"Ramcharitar","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2012.02.022","article-title":"Distinct models of induced hyperactivity in zebrafish larvae","volume":"1449","author":"Ellis","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pbb.2016.03.010","article-title":"Anxiety-related behavioral responses of pentylenetetrazole-treated zebrafish larvae to light-dark transitions","volume":"145","author":"Peng","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.01.040_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2012.00068","article-title":"A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response","volume":"6","author":"Griffiths","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1073\/pnas.90.1.327","article-title":"Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer","volume":"90","author":"Hino","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0295","first-page":"1206","article-title":"Hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jneumeth.2015.06.008","article-title":"Animal models of tumour-associated epilepsy","volume":"260","author":"Kirschstein","year":"2015","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2019.01.040_bib0305","series-title":"From TOP mRNAs to Cell Size","article-title":"Chapter 3 ribosomal protein S6 kinase","author":"Meyuhas","year":"2009"},{"key":"10.1016\/j.bbr.2019.01.040_bib0310","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbr.2019.01.040_bib0315","first-page":"1","article-title":"Developmental effects of cannabidiol and \u03949-Tetrahydrocannabinol in zebrafish","volume":"0","author":"Carty","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0320","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2014.11.013","article-title":"Tuberous sclerosis somplex: a survey of health care resource use and health burden","volume":"52","author":"Rentz","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neulet.2011.09.058","article-title":"5HT1Aand 5HT1Breceptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats","volume":"504","author":"Solati","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.01.040_bib0330","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbr.2010.05.002","article-title":"5HT-1A receptors and anxiety-like behaviours: studies in rats with constitutionally upregulated\/downregulated serotonin transporter","volume":"213","author":"Bordukalo-Niksic","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0335","first-page":"1","article-title":"Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram\u2019s anxiogenic effects in the novelty-induced hypophagia test in mice?","author":"Koek","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pnpbp.2014.03.008","article-title":"Serotonergic modulation of zebrafish behavior: towards a paradox","volume":"55","author":"Herculano","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2019.01.040_bib0345","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0350","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood \u2013 brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5- HT 1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0355","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5b00342","article-title":"Serotonergic modulation as effective treatment for dravet syndrome in a zebrafish mutant model","author":"Sourbron","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0360","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuropharm.2013.03.006","article-title":"Role of serotonin in zebrafish (Danio rerio) anxiety: relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models","volume":"71","author":"Maximino","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.01.040_bib0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.03.025","article-title":"Patterns of avoidance behaviours in the light\/dark preference test in young juvenile zebrafis : a pharmacological study","volume":"222","author":"Steenbergen","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.01.040_bib0370","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1535-7511.2005.00064.x","article-title":"Imaging of serotonin mechanisms in epilepsy","volume":"5","author":"Chugani","year":"2005","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.bbr.2019.01.040_bib0375","first-page":"416","article-title":"PET studies in epilepsy","volume":"5","author":"Sarikaya","year":"2015","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bbr.2019.01.040_bib0380","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3182a08f3f","article-title":"A-[11C]-Methyl-L-tryptophan\u2013PET in191 patients with tuberous sclerosis complex","volume":"81","author":"Chugani","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2019.01.040_bib0385","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers","volume":"63","author":"Talos","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0390","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.S21.001","article-title":"Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) (S21.001)","volume":"88","author":"French","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2019.01.040_bib0395","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/ddq491","article-title":"Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex","volume":"20","author":"Zeng","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2019.01.040_bib0400","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI44909","article-title":"Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice","volume":"121","author":"Feliciano","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2019.01.040_bib0405","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/dvg.22377","article-title":"Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells","volume":"51","author":"Fu","year":"2013","journal-title":"Genesis"},{"key":"10.1016\/j.bbr.2019.01.040_bib0410","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/epi.12545","article-title":"Developmental brain abnormalities in tuberous sclerosis complex : a comparative tissue analysis of cortical tubers and perituberal cortex","volume":"55","author":"Ruppe","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2019.01.040_bib0415","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","article-title":"Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice","volume":"488","author":"Tsai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2019.01.040_bib0420","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijdevneu.2013.02.008","article-title":"A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits","volume":"31","author":"Feliciano","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0425","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbr.2019.01.040_bib0430","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neulet.2011.02.037","article-title":"Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis","volume":"497","author":"McDaniel","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.01.040_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152538","article-title":"DMSO represses inflammatory cytokine production from human blood cells and reduces autoimmune arthritis","volume":"11","author":"Elisia","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.01.040_bib0440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dci.2011.11.004","article-title":"Characterisation, expression and ontogeny of interleukin-6 and its receptors in zebrafish (Danio rerio)","volume":"37","author":"Varela","year":"2012","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0445","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10616-012-9530-6","article-title":"Considerations regarding use of solvents in in vitro cell based assays","volume":"65","author":"Timm","year":"2013","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbr.2019.01.040_bib0450","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cellsig.2016.04.004","article-title":"Interleukin-6 influences stress-signalling by reducing the expression of the mTOR-inhibitor REDD1 in a STAT3-dependent manner","volume":"28","author":"Pinno","year":"2016","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbr.2019.01.040_bib0455","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s00535-013-0891-1","article-title":"Interleukin-6 upregulates Th17 response via mTOR\/STAT3 pathway in acute-on-chronic hepatitis B liver failure","volume":"49","author":"Kim","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbr.2019.01.040_bib0460","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","article-title":"Ribosomal protein S6 phosphorylation: from protein synthesis to cell size","volume":"31","author":"Ruvinsky","year":"2006","journal-title":"Trends Biochem. Sci."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818311215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432818311215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:07:49Z","timestamp":1720948069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432818311215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":92,"alternative-id":["S0166432818311215"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.01.040","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}